Cargando…
The global burden of HIV-1 drug resistance in the past 20 years
Genotypic drug resistance testing has been an integral part of the clinical management of HIV patients for almost 20 years, not only assisting treatment choices but also informing drug development. Accurate estimations on the worldwide circulation of drug resistance are difficult to obtain, particul...
Autores principales: | Zazzi, Maurizio, Hu, Hui, Prosperi, Mattia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971836/ https://www.ncbi.nlm.nih.gov/pubmed/29844989 http://dx.doi.org/10.7717/peerj.4848 |
Ejemplares similares
-
Limited Marginal Utility of Deep Sequencing for HIV Drug Resistance Testing in the Age of Integrase Inhibitors
por: Dalmat, Ronit R., et al.
Publicado: (2018) -
Globalization of Chikungunya: 10 years to invade the world
por: Charrel, R. N., et al.
Publicado: (2014) -
An HIV Diagnostic Testing Algorithm Using the cobas HIV-1/HIV-2 Qualitative Assay for HIV Type Differentiation and Confirmation
por: Duncan, Dana, et al.
Publicado: (2021) -
Identification of Acute HIV-1 Infection by Hologic Aptima HIV-1 RNA Qualitative Assay
por: Manak, Mark M., et al.
Publicado: (2017) -
Eradication of drug-resistant Acinetobacter baumannii by cell-penetrating peptide fused endolysin
por: Lim, Jeonghyun, et al.
Publicado: (2022)